高级检索
当前位置: 首页 > 详情页

Circular RNA circSDHC (hsa_circ_0015004) regulates tumor growth and angiogenesis via regulating centrosomal protein 55 expression in renal cell carcinoma.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Urology, The Fourth Hospital of Hebei Medical University,Shijiazhuang City, Hebei Province, China.
出处:
ISSN:

关键词: RCC circSDHC miR-130a-3p CEP55

摘要:
Renal cell carcinoma (RCC) is the main aggressive subtype of kidney cancer. Circular RNAs have been shown to exert critical roles in RCC. However, little is known about the regulatory mechanism of hsa_circ_0015004 (circSDHC) in RCC.35 patients with RCC were recruited in the research. Expression changes of circSDHC were determined by real-time quantitative polymerase chain reaction (RT-qPCR). The effects of circSDHC inhibition on cell proliferation, apoptosis, angiogenesis, migration, and invasion were analyzed. The regulation mechanism of circSDHC was surveyed by bioinformatics analysis. The effect of circSDHC on tumorigenesis was validated by xenograft assay.We observed an observable elevation in circSDHC expression in RCC tissues and cell lines. Functionally, circSDHC silencing decreased xenograft tumor growth and induced RCC cell apoptosis, repressed RCC cell proliferation, angiogenesis, migration, and invasion in vitro. Mechanically, circSDHC modulated centrosomal protein 55 (CEP55) expression by functioning as a miR-130a-3p sponge. Also, miR-130a-3p silencing offset circSDHC knockdown-mediated impacts on malignant phenotypes and angiogenesis of RCC cells. Furthermore, exogenetic expression of CEP55 counteracted miR-130a-3p overexpression-mediated effects on malignant phenotypes and angiogenesis of RCC cells.Silencing of circSDHC restrained cell malignant phenotypes and angiogenesis via reducing CEP55 expression by releasing miR-130a-3p in RCC, providing a new mechanism for understanding the progression of RCC.©The Author(s) 2022. Open Access. This article is licensed under a Creative Commons CC-BY International License.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2022]版:
大类 | 4 区 生物学
小类 | 4 区 细胞生物学 4 区 病理学
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 细胞生物学 4 区 病理学
JCR分区:
出版当年[2022]版:
Q3 PATHOLOGY Q4 CELL BIOLOGY
最新[2023]版:
Q2 PATHOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Urology, The Fourth Hospital of Hebei Medical University,Shijiazhuang City, Hebei Province, China.
通讯作者:
通讯机构: [1]Department of Urology, The Fourth Hospital of Hebei Medical University,Shijiazhuang City, Hebei Province, China. [*1]Department of Urology, The Fourth Hospital of Hebei Medical University, 050000, No. 12, Jiankang Road, Chang'an District,Shijiazhuang City, 050000, Hebei Province, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号